Four Anti-dsDNA Antibody Assays in Relation to Systemic Lupus Erythematosus Disease Specificity and Activity

REFERENCES

1. 1.↵
   1. Rahman A,
   2. Isenberg DA

   . Systemic lupus erythematosus. N Engl J Med 2008;358:929–39.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Tan EM,
   2. Cohen AS,
   3. Fries JF,
   4. Masi AT,
   5. McShane DJ,
   6. Rothfield NF,
   7. et al.

   The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Petri M,
   2. Orbai AM,
   3. Alarcon GS,
   4. Gordon C,
   5. Merrill JT,
   6. Fortin PR,
   7. et al.

   Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012;64:2677–86.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Isenberg DA,
   2. Manson JJ,
   3. Ehrenstein MR,
   4. Rahman A

   . Fifty years of anti-ds DNA antibodies: are we approaching journey’s end? Rheumatology 2007;46:1052–6.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Tan EM,
   2. Schur PH,
   3. Carr RI,
   4. Kunkel HG

   . Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus. J Clin Invest 1966;45:1732–40.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Krishnan C,
   2. Kaplan MH

   . Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest 1967;46:569–79.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Koffler D,
   2. Schur PH,
   3. Kunkel HG

   . Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 1967;126:607–24.

   OpenUrlAbstract
8. 8.↵
   1. Vlahakos DV,
   2. Foster MH,
   3. Adams S,
   4. Katz M,
   5. Ucci AA,
   6. Barrett KJ,
   7. et al.

   Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites. Kidney Int 1992;41:1690–700.

   OpenUrlCrossRefPubMed
9. 9.↵
   1. Aarden LA,
   2. de Groot ER,
   3. Feltkamp TE

   . Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci 1975;254:505–15.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Kavanaugh AF,
    2. Solomon DH;
    3. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines

    . Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum 2002;47:546–55.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Irving KS,
    2. Sen D,
    3. Tahir H,
    4. Pilkington C,
    5. Isenberg DA

    . A comparison of autoimmune liver disease in juvenile and adult populations with systemic lupus erythematosus–a retrospective review of cases. Rheumatology 2007;46:1171–3.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Czaja AJ,
    2. Cassani F,
    3. Cataleta M,
    4. Valentini P,
    5. Bianchi FB

    . Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology 1996;24:1068–73.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Eriksson C,
    2. Kokkonen H,
    3. Johansson M,
    4. Hallmans G,
    5. Wadell G,
    6. Rantapää-Dahlqvist S

    . Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden. Arthritis Res Ther 2011;13:R30.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Winfield JB,
    2. Faiferman I,
    3. Koffler D

    . Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis. J Clin Invest 1977;59:90–6.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Cervera R,
    2. Khamashta MA,
    3. Font J,
    4. Sebastiani GD,
    5. Gil A,
    6. Lavilla P,
    7. et al.

    Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine 1993;72:113–24.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Julkunen H,
    2. Ekblom-Kullberg S,
    3. Miettinen A

    . Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol Int 2012;32:2445–51.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Haugbro K,
    2. Nossent JC,
    3. Winkler T,
    4. Figenschau Y,
    5. Rekvig OP

    . Anti-dsDNA antibodies and disease classification in antinuclear antibody positive patients: the role of analytical diversity. Ann Rheum Dis 2004;63:386–94.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Launay D,
    2. Schmidt J,
    3. Lepers S,
    4. Mirault T,
    5. Lambert M,
    6. Kyndt X,
    7. et al.

    Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus. Clin Chim Acta 2010;411:959–64.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Eaton RB,
    2. Schnneider G,
    3. Schur PH

    . Enzyme immunoassay for antibodies to native DNA. Specificity and quality of antibodies. Arthritis Rheum 1983;26:52–62.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Isenberg DA,
    2. Dudeney C,
    3. Williams W,
    4. Addison I,
    5. Charles S,
    6. Clarke J,
    7. et al.

    Measurement of anti-DNA antibodies: a reappraisal using five different methods. Ann Rheum Dis 1987;46:448–56.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Enocsson H,
    2. Wetterö J,
    3. Skogh T,
    4. Sjöwall C

    . Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus. Transl Res 2013;162:287–96.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Frodlund M,
    2. Dahlström O,
    3. Kastbom A,
    4. Skogh T,
    5. Sjöwall C

    . Associations between antinuclear antibody staining patterns and clinical features of systemic lupus erythematosus: analysis of a regional Swedish register. BMJ Open 2013;3:e003608.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Gladman DD,
    2. Ibañez D,
    3. Urowitz MB

    . Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002;29:288–91.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Scott DL

    . A simple index to assess disease activity in rheumatoid arthritis. J Rheumatol 1993;20:582–4.

    OpenUrlPubMed
25. 25.↵
    1. Vitali C,
    2. Bombardieri S,
    3. Jonsson R,
    4. Moutsopoulos HM,
    5. Alexander EL,
    6. Carsons SE,
    7. et al.

    Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554–8.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Kastbom A,
    2. Strandberg G,
    3. Lindroos A,
    4. Skogh T

    . Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004;63:1085–9.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Enocsson H,
    2. Sjöwall C,
    3. Skogh T,
    4. Eloranta ML,
    5. Rönnblom L,
    6. Wetterö J

    . Interferon-alpha mediates suppression of C-reactive protein: explanation for muted C-reactive protein response in lupus flares? Arthritis Rheum 2009;60:3755–60.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Cederblad B,
    2. Blomberg S,
    3. Vallin H,
    4. Perers A,
    5. Alm GV,
    6. Rönnblom L

    . Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells. J Autoimmun 1998;11:465–70.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Bootsma H,
    2. Spronk PE,
    3. Hummel EJ,
    4. de Boer G,
    5. ter Borg EJ,
    6. Limburg PC,
    7. et al.

    Anti-double stranded DNA antibodies in systemic lupus erythematosus: detection and clinical relevance of IgM-class antibodies. Scand J Rheumatol 1996;25:352–9.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Förger F,
    2. Matthias T,
    3. Oppermann M,
    4. Becker H,
    5. Helmke K

    . Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis. Lupus 2004;13:36–44.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Villalta D,
    2. Bizzaro N,
    3. Bassi N,
    4. Zen M,
    5. Gatto M,
    6. Ghirardello A,
    7. et al.

    Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS One 2013;8:e71458.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Hopkinson ND,
    2. Jenkinson C,
    3. Muir KR,
    4. Doherty M,
    5. Powell RJ

    . Racial group, socioeconomic status, and the development of persistent proteinuria in systemic lupus erythematosus. Ann Rheum Dis 2000;59:116–9.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Hernando M,
    2. González C,
    3. Sánchez A,
    4. Guevara P,
    5. Navajo JA,
    6. Papisch W,
    7. et al.

    Clinical evaluation of a new automated anti-dsDNA fluorescent immunoassay. Clin Chem Lab Med 2002;40:1056–60.

    OpenUrlCrossRefPubMed
34. 34.↵
    1. Antico A,
    2. Platzgummer S,
    3. Bassetti D,
    4. Bizzaro N,
    5. Tozzoli R,
    6. Villalta D,
    7. et al.

    Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test. Lupus 2010;19:906–12.

    OpenUrlAbstract/FREE Full Text
35. 35.↵
    1. Martin J,
    2. Durant C,
    3. Rimbert M,
    4. Hemont C,
    5. Hamidou M,
    6. Audrain M

    . Evaluation of two antibodies against double-stranded DNA assays in discriminating between active and non-active systemic lupus erythematosus: correlation between the cut-off and the specificity. Pathol Biol 2012;60:387–91.

    OpenUrlCrossRefPubMed